Products for Research Use Only

Bazedoxifene

CAT: 0804-HY-A0031-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-A0031-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene can be used for the research of osteoporosis. Bazedoxifene also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer[1][2].
CAS Number
198481-32-2
Product Name Alternative
TSE-424
UNSPSC
12352005
Hazard Statement
H360
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bazedoxifene.html
Concentration
10mM
Purity
99.35
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(C2=CC=C(O)C=C2)N(CC3=CC=C(OCCN4CCCCCC4)C=C3)C5=CC=C(O)C=C51
Molecular Formula
C30H34N2O3
Molecular Weight
470.60
Precautions
H360
References & Citations
[1]Barry S Komm, et al. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology. 2005 Sep;146 (9) :3999-4008.|[2]Xiaojuan Wu, et al. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. Mol Cancer Ther. 2016 Nov; 15 (11) : 2609–2619.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
Arch Biochem Biophys. 2025 Jun:768:110366.|biorxiv. 2024 May 21.|Breast Cancer Res Treat. 2020 Jan;179 (1) :67-77.|Eur J Pharmacol. 2023 May 15:947:175681.|Free Radic Biol Med. 2023 Aug 20:205:163-174.|Glia. 2023 Feb;71 (2) :284-304.|Gynecol Oncol. 2019 Jul;154 (1) :199-206.|J Cell Biochem. 2023 Sep;124 (9) :1404-1422.|Res Sq. 2020 Dec 31:rs.3.rs-100914.|Research Square Preprint. 2022 Jul.|University of Colorado Denver. 2024.|Cell Rep Methods. 2023 Oct 23;3 (10) :100599.|J Med Chem. 2020 Oct 8;63 (19) :11085-11099.|mSphere. 2020 Apr 8;5 (2) :e00124-20.